PhaseRx Garners $1,400,014 New Financing Round

  • Feed Type
  • Date
    10/3/2013
  • Company Name
    PhaseRx
  • Mailing Address
    410 West Harrison Street Seattle, WA 98119
  • Company Description
    PhaseRx is an RNAi delivery technology company developing a breakthrough polymer-based system that enables the systemic delivery of RNAi-based drugs and potentially other macromolecules as therapeutic products.
  • Website
    http://www.phaserx.com
  • Transaction Type
    Debt
  • Transaction Amount
    $1,400,014
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.